Test: |
Chikungunya Virus Antibodies, IgM
|
Synonym: |
Arbovirus, Chikungunya virus serology
|
Method: |
ELISA
|
Availability: |
Test performed Monday-Friday ; Turn-around time 7 days
|
Specimen: |
https://arupconsult.com/content/mosquito-borne-arboviruses#toc-arup-laboratory-tests
|
Collection Device: |
https://arupconsult.com/content/mosquito-borne-arboviruses#toc-arup-laboratory-tests
|
Volume: |
https://arupconsult.com/content/mosquito-borne-arboviruses#toc-arup-laboratory-tests
|
Storage/Transport: |
Centrifuge and aliquot serum into sterile leak-proof tube, ASAP. Place both CSF and serum at 4°C.
Shipping instructions, including specimen handling requirements during transport: Package and ship as UN3373 Category B, Biological Substance. Place in biohazard bag with absorbent material. Refrigerated specimen should be shipped on cold packs Transport by NPHL ground courier (NPHL brown shipper not required). If courier not available, contact Client Services (866) 290-1406 to arrange pickup.
See instructions and shipping address: http://nphl.org/. Do not send directly to CDC.
|
Unacceptable: |
Severely lipemic, icteric or hemolyzed samples; heat-inactivated serum; multiple freeze thaw cycles.
|
Specimen Stability: |
After separation from cells: Ambient 2-8°C for 48h; Refrigerated Refrigerate 2-8°C for 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|
Reference Interval: |
Negative - No significant level of detectable chikungunya virus IgM antibody.
Equivocal - Questionable presence of antibodies. Repeat testing in 10-14 days may be helpful.
Positive –IgM antibody to chikungunya virus detected, which may indicate a current or past infection.
|
Reportable Disease: |
A positive result is reportable as Arbovirus infection under Title 173, report within 7 days
|
Comments: |
Pre-approval needed from the state or local health department. Send approval to NPHL@unmc.edu or call (402) 559-9444.
Test Request Order Form must accompany the specimen to include the following information: symptoms and date of onset, pregnancy status, travel and vaccine history.
|
Revised: |
3/15/2021 |